tak 779 has been researched along with Bone Loss, Osteoclastic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coulton, L; Croucher, P; De Leenheer, E; De Raeve, H; Horuk, R; Imanishi, T; Menu, E; Miyashita, K; Van Camp, B; Van Riet, I; Van Valckenborgh, E; Vanderkerken, K | 1 |
1 other study(ies) available for tak 779 and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model.
Topics: Amides; Animals; Bone Marrow; Bone Resorption; CCR5 Receptor Antagonists; Cell Division; Cell Line, Tumor; Cell Movement; Chemokine CCL3; Chemokine CCL4; Chemokines, CC; Chemotaxis; Female; Macrophage Inflammatory Proteins; Mice; Mice, Inbred C57BL; Multiple Myeloma; Neoplasm Proteins; Neovascularization, Pathologic; Osteoclasts; Osteolysis; Phenylurea Compounds; Piperidines; Quaternary Ammonium Compounds; Receptors, CCR1; Receptors, CCR5; Receptors, Chemokine; Recombinant Fusion Proteins; Stromal Cells; Tumor Burden | 2006 |